CCL8 and inflammatory bowel disease: It has been shown that CCL8 was overexpressed in the intestines of DSS-induced mice and active IBD patients, and inhibition of CCL8 exhibited a potential therapeutic effect in DSS-induced mice (Asano et al., 2015; Jones et al., 2018).